Edith Bigot-Corbel - JoVE Visualize

Showing results (21-30 of 55) with videos related to

Pageof 6

Sort By:

Annales De Biologie Clinique|February 26, 2019

Interest of albuminuria in nephrology, diabetology and as a marker of cardiovascular riskJean-Sébastien Souweine, Alice Corbel, Claire Rigothier, et al.

Journal of Clinical Medicine|March 10, 2022

Effect of Parathyroidectomy on Metabolic Homeostasis in Primary HyperparathyroidismSamuel Frey, Raphaël Bourgade, Cédric Le May, et al.

Brain Communications|February 8, 2023

Idiopathic normal pressure hydrocephalus and frontotemporal dementia: an unexpected associationAdrien de Guilhem de Lataillade, Claire Boutoleau-Bretonnière, Jesus Aguilar-Garcia, et al.

The Journal of Clinical Endocrinology and Metabolism|December 28, 2023

Parathyroidectomy Improves Bone Density in Women With Primary Hyperparathyroidism and Preoperative OsteopeniaSamuel Frey, Maxime Gérard, Pascale Guillot, et al.

Annales De Biologie Clinique|February 11, 2021

[SARS-CoV-2 and neurological disorders: the revelance of biomarkers?]Edith Bigot-Corbel, Aymeric Lanore, Celia Raulet, et al.

Frontiers in Medicine|November 20, 2015

Single-Dose Anti-CD138 Radioimmunotherapy: Bismuth-213 is More Efficient than Lutetium-177 for Treatment of Multiple Myeloma in a Preclinical ModelNolwenn Fichou, Sébastien Gouard, Catherine Maurel, et al.

Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 1, 2019

Frontotemporal dementia is the leading cause of "true" A-/T+ profiles defined with Aβ42/40 ratioHélène Pouclet-Courtemanche, Tri-Bao Nguyen, Emilie Skrobala, et al.

Frontiers in Immunology|June 16, 2020

Analysis of the Targets and Glycosylation of Monoclonal IgAs From MGUS and Myeloma PatientsAdrien Bosseboeuf, Célia Seillier, Nicolas Mennesson, et al.

Frontiers in Immunology|January 28, 2022

Efficacy of Antiviral Treatment in Hepatitis C Virus (HCV)-Driven Monoclonal Gammopathies Including MyelomaAlba Rodríguez-García, María Linares, María Luz Morales, et al.

Cancers|May 21, 2020

Characteristics of MGUS and Multiple Myeloma According to the Target of Monoclonal Immunoglobulins, Glucosylsphingosine, or Epstein-Barr Virus EBNA-1Adrien Bosseboeuf, Nicolas Mennesson, Sophie Allain-Maillet, et al.

Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:

Pageof 6

Annales De Biologie Clinique|February 26, 2019

Interest of albuminuria in nephrology, diabetology and as a marker of cardiovascular riskJean-Sébastien Souweine, Alice Corbel, Claire Rigothier, et al.

Journal of Clinical Medicine|March 10, 2022

Effect of Parathyroidectomy on Metabolic Homeostasis in Primary HyperparathyroidismSamuel Frey, Raphaël Bourgade, Cédric Le May, et al.

Brain Communications|February 8, 2023

Idiopathic normal pressure hydrocephalus and frontotemporal dementia: an unexpected associationAdrien de Guilhem de Lataillade, Claire Boutoleau-Bretonnière, Jesus Aguilar-Garcia, et al.

The Journal of Clinical Endocrinology and Metabolism|December 28, 2023

Parathyroidectomy Improves Bone Density in Women With Primary Hyperparathyroidism and Preoperative OsteopeniaSamuel Frey, Maxime Gérard, Pascale Guillot, et al.

Annales De Biologie Clinique|February 11, 2021

[SARS-CoV-2 and neurological disorders: the revelance of biomarkers?]Edith Bigot-Corbel, Aymeric Lanore, Celia Raulet, et al.

Frontiers in Medicine|November 20, 2015

Single-Dose Anti-CD138 Radioimmunotherapy: Bismuth-213 is More Efficient than Lutetium-177 for Treatment of Multiple Myeloma in a Preclinical ModelNolwenn Fichou, Sébastien Gouard, Catherine Maurel, et al.

Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 1, 2019

Frontotemporal dementia is the leading cause of "true" A-/T+ profiles defined with Aβ42/40 ratioHélène Pouclet-Courtemanche, Tri-Bao Nguyen, Emilie Skrobala, et al.

Frontiers in Immunology|June 16, 2020

Analysis of the Targets and Glycosylation of Monoclonal IgAs From MGUS and Myeloma PatientsAdrien Bosseboeuf, Célia Seillier, Nicolas Mennesson, et al.

Frontiers in Immunology|January 28, 2022

Efficacy of Antiviral Treatment in Hepatitis C Virus (HCV)-Driven Monoclonal Gammopathies Including MyelomaAlba Rodríguez-García, María Linares, María Luz Morales, et al.

Cancers|May 21, 2020

Characteristics of MGUS and Multiple Myeloma According to the Target of Monoclonal Immunoglobulins, Glucosylsphingosine, or Epstein-Barr Virus EBNA-1Adrien Bosseboeuf, Nicolas Mennesson, Sophie Allain-Maillet, et al.

Pageof 6